Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Pediatrix Medical Group Yönetim
Yönetim kriter kontrolleri 3/4
Pediatrix Medical Group's CEO'su Jim Swift, Jan2023 tarihinde atandı, in görev süresi 1.75 yıldır. in toplam yıllık tazminatı $ 2.24M olup, şirket hissesi ve opsiyonları dahil olmak üzere 29% maaş ve 71% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.2% ine doğrudan sahiptir ve bu hisseler $ 1.97M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.8 yıl ve 4.3 yıldır.
Anahtar bilgiler
Jim Swift
İcra Kurulu Başkanı
US$2.2m
Toplam tazminat
| CEO maaş yüzdesi | 29.0% |
| CEO görev süresi | 1.8yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 2.5yrs |
| Yönetim Kurulu ortalama görev süresi | 4.3yrs |
Son yönetim güncellemeleri
Recent updates
We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28
Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$252m |
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
Tazminat ve Piyasa: Jim 'nin toplam tazminatı ($USD 2.24M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 3.23M ).
Tazminat ve Kazançlar: Jim şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Jim Swift (62 yo)
1.8yrs
Görev süresi
US$2,237,839
Tazminat
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$2.24m | 0.20% $ 2.1m | |
| Executive VP | 2yrs | US$1.83m | 0.19% $ 1.9m | |
| Senior VP & Chief Accounting Officer | 8.4yrs | US$1.43m | Veri yok | |
| Senior VP & Chief Information Officer | 2.8yrs | Veri yok | Veri yok | |
| Senior Vice President of Administration & Managed Care | no data | Veri yok | Veri yok | |
| Senior VP of Finance | no data | Veri yok | Veri yok | |
| Senior VP | 3.2yrs | Veri yok | Veri yok | |
| President of Regional Operations (Central) | no data | Veri yok | Veri yok | |
| President of Regional Operations (South-Central) | no data | Veri yok | Veri yok | |
| Senior Vice President of Operations | no data | Veri yok | Veri yok | |
| President of Regional Operations (West) | 2.5yrs | Veri yok | Veri yok | |
| Senior Vice President of Medical Administrative Services | 2.4yrs | Veri yok | Veri yok |
2.5yrs
Ortalama Görev Süresi
62yo
Ortalama Yaş
Deneyimli Yönetim: MD 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Director | 1.6yrs | US$2.24m | 0.20% $ 2.1m | |
| Chair | 4.3yrs | US$554.45k | 0.20% $ 2.0m | |
| Lead Independent Director | 4.3yrs | US$295.00k | 0.081% $ 828.7k | |
| Independent Director | 4.3yrs | US$252.50k | 0.065% $ 662.8k | |
| Independent Director | 1.4yrs | US$201.00k | 0.035% $ 354.1k | |
| Independent Director | 4.3yrs | US$230.00k | 0.065% $ 662.7k | |
| Independent Director | 4.3yrs | US$245.00k | 0.043% $ 437.0k | |
| Board Observer | 4.3yrs | Veri yok | Veri yok | |
| Independent Director | 5.4yrs | US$242.50k | 0.069% $ 705.4k | |
| Independent Director | 2.4yrs | US$230.00k | 0.023% $ 235.9k |
4.3yrs
Ortalama Görev Süresi
61yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).